Kathleen T. Brady, MD, PhD

Department of Psychiatry & Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina; Ralph H. Johnson VA Medical Center, Charleston, South Carolina

JCP
Doxazosin for the Treatment of PTSD and AUD
Original Research

March 8, 2023

This study is the first to evaluate doxazosin, an α1-adrenergic antagonist, in veterans with both PTSD and alcohol use disorder.
Sudie E. Back, Julianne C. Flanagan, Jim Mintz, et al
JCP
Original Research

November 23, 2016

Knowing that patients with posttraumatic stress disorder and substance use disorder share impaired prefrontal cortex regulation, particularly at glutamate synapses in the nucleus accumbens, the authors conducted this first-ever...
Sudie E. Back, Jenna L. McCauley, Kristina J. Korte, et al
JCP
Original Research

July 31, 2008

Keming Gao, Marcia L. Verduin, David E. Kemp, et al
JCP
Original Research

March 18, 2008

Barbara O. Rothbaum, Therese K. Killeen, Jonathan R. T. Davidson, et al
JCP
Academic Highlights

July 16, 2007

Richard N. Rosenthal, Kathleen T. Brady, Petros Levounis, et al
JCP
Article

January 1, 2002

Dennis S. Charney, Dale R. Grothe, Sherry L. Smith, et al
JCP
Original Research

January 1, 2001

Hugh Myrick, Scott Henderson, Kathleen T. Brady, et al
JCP
Article

November 30, 2000

Kathleen T. Brady
PCC
Article

April 30, 2000

Kathleen T. Brady, Therese K. Killeen, Tim Brewerton, et al
JCP
Article

April 30, 2000

Kathleen T. Brady, Therese K. Killeen, Tim Brewerton, et al
JCP
Article

March 1, 1997

Kathleen T. Brady

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe